Consider |
Who?
|
Urologist |
What?
|
Clinical trial as a treatment option |
When?
|
Prior to treatment decision |
Where?
|
At location of results review |
How often?
|
At each cancer diagnosis |
With whom?
|
Each diagnosed cancer patient |
Counsel |
Who?
|
Urologist |
What?
|
Clinical trials are a treatment option |
When?
|
At first treatment counseling visit |
Where?
|
In the exam room |
How often?
|
Every initial cancer treatment counseling visit |
With whom?
|
All patients meeting broad eligibility criteria (determined by flow sheet) |
Refer |
Who?
|
Urologist |
What?
|
Signal to patient and cancer program that patient is recommended for clinical trial eligibility screening |
When?
|
During and immediately following treatment counseling visit |
Where?
|
Exam room and location where charting is performed |
How often?
|
Each time clinical trial is included in treatment counseling |
With whom?
|
All patients meeting broad eligibility criteria (determined by flow sheet) who do not refuse referral |
Notify |
Who?
|
Urologist or designated clinic staff |
What?
|
Cancer patient is scheduling visit for clinical trial eligibility screening |
When?
|
At patient’s convenience in next 3 weeks |
Where?
|
Immediately following treatment counseling visit |
How often?
|
Each time referral is documented |
With whom?
|
All patients meeting broad eligibility criteria (determined by flow sheet) who do not refuse referral |